Update
$Opko Health (OPK.US)$ $Entera Bio (ENTX.US)$ Reuters· 1 min
Entera Bio and OPKO Health Provide Update on Pk/Pd Results of Oral Oxyntomodulin (GLP-1/Glucagon) Peptide Tablet Candidate for Obesity and Metabolic Disorders
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
Trytosaveabit OP : Entera Bio Ltd - Oral Oxm Reduced Plasma Glucose Levels Significantly